LeimgruberK., NegroR., BaierS., MoserB., ReschG., SansoneS., AdamiM., ZanonP., GraiffC., Egarter-ViglE., WiedermannC.J.: Fatal interstitial pneumonitis associated with docetaxel administration in a patient with hormone-refractory prostate cancer. Tumori, 92: 542–544, 2006.
2.
ChoyH., RodriguezF.F., KoesterS., HilsenbeckS., Von HoffD.D.: Investigation of taxol as a potential radiation sensitizer. Cancer, 71: 3774–3778, 1993.
3.
GlantzM.J., ChoyH., AkerleyW., KearnsC.M., EgorinM.J., RhodesC.H., ColeB.F.: Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response. Semin Oncol, 6: 128–135, 1996.
4.
Cüneyt UlutinH., PakY.: Preliminary results of radiotherapy with or without weekly paclitaxel in locally advanced non-small cell lung cancer. J Cancer Res Clin Oncol, 129: 52–56, 2003.
5.
UlutinH.C., KuzhanO., OzturkB.: Plasma transforming growth factor, 1 as a new prognostic and predictive marker in non-small cell lung cancer. Sendrom, 17: 33–35, 2005.
6.
UlutinH.C., AksuG.: Radiotherapy and surgery in the management of non-small cell lung cancer in the elderly patients, a review of the literature. Cancer Therapy, 3: 95–100, 2005.
